PL130530B1 - Process for manufacturing novel heterocyclic derivatives of thioformamide - Google Patents
Process for manufacturing novel heterocyclic derivatives of thioformamide Download PDFInfo
- Publication number
- PL130530B1 PL130530B1 PL1981230552A PL23055281A PL130530B1 PL 130530 B1 PL130530 B1 PL 130530B1 PL 1981230552 A PL1981230552 A PL 1981230552A PL 23055281 A PL23055281 A PL 23055281A PL 130530 B1 PL130530 B1 PL 130530B1
- Authority
- PL
- Poland
- Prior art keywords
- solution
- methyl
- pyridyl
- minutes
- temperature
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Instructional Devices (AREA)
- Lasers (AREA)
- Toys (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8018035A FR2488609A1 (fr) | 1980-08-18 | 1980-08-18 | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL230552A1 PL230552A1 (enExample) | 1982-03-01 |
| PL130530B1 true PL130530B1 (en) | 1984-08-31 |
Family
ID=9245232
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1981230552A PL130530B1 (en) | 1980-08-18 | 1981-04-07 | Process for manufacturing novel heterocyclic derivatives of thioformamide |
| PL1981239331A PL130679B1 (en) | 1980-08-18 | 1981-04-07 | Process for preparing novel heterocyclic derivatives of thioformamide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1981239331A PL130679B1 (en) | 1980-08-18 | 1981-04-07 | Process for preparing novel heterocyclic derivatives of thioformamide |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4379154A (enExample) |
| EP (2) | EP0077083B1 (enExample) |
| JP (1) | JPS5742687A (enExample) |
| KR (1) | KR850001043B1 (enExample) |
| AT (1) | ATE14730T1 (enExample) |
| CA (1) | CA1161039A (enExample) |
| DE (1) | DE3161861D1 (enExample) |
| DK (1) | DK158735C (enExample) |
| ES (2) | ES8202819A1 (enExample) |
| FI (1) | FI810835L (enExample) |
| FR (1) | FR2488609A1 (enExample) |
| GR (1) | GR72767B (enExample) |
| HU (1) | HU187325B (enExample) |
| IE (1) | IE51263B1 (enExample) |
| IL (1) | IL62380A (enExample) |
| MA (1) | MA19106A1 (enExample) |
| NO (1) | NO810962L (enExample) |
| NZ (1) | NZ197071A (enExample) |
| OA (1) | OA06767A (enExample) |
| PH (1) | PH16520A (enExample) |
| PL (2) | PL130530B1 (enExample) |
| PT (1) | PT72718B (enExample) |
| SU (2) | SU1093248A3 (enExample) |
| ZA (1) | ZA813159B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2511371A1 (fr) * | 1981-08-11 | 1983-02-18 | Rhone Poulenc Sante | Nouveaux nitriles heterocycliques, leur preparation et leur utilisation pour la preparation de medicaments |
| FR2528849B1 (fr) * | 1982-06-17 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
| FR2573428B1 (fr) * | 1984-11-20 | 1987-01-30 | Rhone Poulenc Sante | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
| GB8907306D0 (en) * | 1989-03-31 | 1989-05-17 | May & Baker Ltd | New compositions of matter |
| FR2653770B1 (fr) * | 1989-10-31 | 1992-01-03 | Rhone Poulenc Sante | Procede de preparation de (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r), les (pyridyl-3)-2 tetrhydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r) ainsi obtenus et les compositions pharmaceutiques qui les contiennent. |
| JPH04211048A (ja) * | 1990-03-05 | 1992-08-03 | Mitsubishi Kasei Corp | チオカルバモイルアセトニトリル誘導体 |
| CA2119876A1 (en) * | 1991-10-14 | 1993-04-29 | Yasuhiro Kabasawa | Thioformamide derivative |
| US5625068A (en) * | 1995-06-05 | 1997-04-29 | American Cyanamid Company | Substituted quinoline herbicide intermediates and process |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2100970B1 (enExample) * | 1970-07-30 | 1975-08-01 | Fujisawa Pharmaceutical Co | |
| DK627174A (enExample) * | 1974-01-17 | 1975-09-08 | Ciba Geigy Ag | |
| FR2452488A1 (fr) * | 1979-03-30 | 1980-10-24 | Rhone Poulenc Ind | Nouveaux derives du (pyridyl-2)-2 tetrahydrothiophene, leur preparation et les medicaments qui les contiennent |
| IE49570B1 (en) * | 1979-03-30 | 1985-10-30 | Rhone Poulenc Ind | 2-(pyrid-2-yl)tetrahydrothiophene derivatives |
| JPS6134433A (ja) * | 1984-08-31 | 1986-02-18 | Nippon Telegr & Teleph Corp <Ntt> | ｘｙ平面位置決め用アクチユエ−タ装置 |
-
1980
- 1980-08-18 FR FR8018035A patent/FR2488609A1/fr active Granted
-
1981
- 1981-03-12 AT AT82110740T patent/ATE14730T1/de not_active IP Right Cessation
- 1981-03-12 OA OA57352BISD patent/OA06767A/xx unknown
- 1981-03-12 EP EP82110740A patent/EP0077083B1/fr not_active Expired
- 1981-03-12 EP EP81400381A patent/EP0046417B1/fr not_active Expired
- 1981-03-12 DE DE8181400381T patent/DE3161861D1/de not_active Expired
- 1981-03-16 IL IL62380A patent/IL62380A/xx unknown
- 1981-03-18 HU HU81698A patent/HU187325B/hu unknown
- 1981-03-18 FI FI810835A patent/FI810835L/fi not_active Application Discontinuation
- 1981-03-20 GR GR64458A patent/GR72767B/el unknown
- 1981-03-20 NO NO810962A patent/NO810962L/no unknown
- 1981-03-21 MA MA19312A patent/MA19106A1/fr unknown
- 1981-03-23 PT PT72718A patent/PT72718B/pt unknown
- 1981-03-23 DK DK130781A patent/DK158735C/da not_active IP Right Cessation
- 1981-04-03 ES ES501060A patent/ES8202819A1/es not_active Expired
- 1981-04-07 PL PL1981230552A patent/PL130530B1/pl unknown
- 1981-04-07 PL PL1981239331A patent/PL130679B1/pl unknown
- 1981-04-10 SU SU813266246A patent/SU1093248A3/ru active
- 1981-05-11 IE IE1036/81A patent/IE51263B1/en unknown
- 1981-05-12 NZ NZ197071A patent/NZ197071A/xx unknown
- 1981-05-12 ZA ZA00813159A patent/ZA813159B/xx unknown
- 1981-05-14 CA CA000377595A patent/CA1161039A/fr not_active Expired
- 1981-05-18 US US06/264,550 patent/US4379154A/en not_active Expired - Fee Related
- 1981-05-29 JP JP56081187A patent/JPS5742687A/ja active Granted
- 1981-05-30 KR KR1019810001943A patent/KR850001043B1/ko not_active Expired
- 1981-07-07 ES ES503727A patent/ES503727A0/es active Granted
-
1982
- 1982-03-29 SU SU823415750A patent/SU1209029A3/ru active
- 1982-06-01 PH PH25692A patent/PH16520A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050038035A1 (en) | Heterocyclic amide compounds as apolipoprotein b inhibitors | |
| KR900003490B1 (ko) | 쯔비터이온성 비사이클릭 화합물 및 이의 염, 용매화물, 수화물 및 에스테르, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| HU180945B (en) | Process for preparing pyrimidones | |
| US5089495A (en) | Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives | |
| CH631981A5 (en) | Process for preparing novel derivatives of pyrimid-4-one and pyrimid-4-thione, and their salts with acids | |
| PL130530B1 (en) | Process for manufacturing novel heterocyclic derivatives of thioformamide | |
| EP0007678B1 (en) | Oxime ethers, their preparation and pharmaceutical compositions containing them | |
| DE3782621T2 (de) | Imidazol-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, welche diese enthalten, verwendung dieser zur herstellung therapeutisch wirksamer arzneimittel und zwischenprodukte, welche beim herstellungsverfahren entstehen. | |
| JPH0345073B2 (enExample) | ||
| IE860125L (en) | Piperazinyl pyridines | |
| CA1093074A (en) | Substituted oximino anti-ulcer compounds and compositions | |
| KR100248643B1 (ko) | 아릴 및 헤테로아릴 알콕시나프탈렌 유도체 | |
| EP0057981A2 (en) | Aromatic compounds, processes for their preparation and their use | |
| US4859679A (en) | Antiulcer (alkyldithio) quinoline derivatives | |
| FI66862C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-(pyridyl-2)-tetrahydrotiofenderivat | |
| EP0039989B1 (en) | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| EP0083186B1 (en) | Thiazole derivatives as h2-receptor antagonists | |
| HU193362B (en) | Process for preparing imidazole derivatives | |
| CA1260938A (en) | Pyrimidine-thioalkyl pyridine derivatives, a process for their production and medicaments containing these compounds | |
| CA1297109C (en) | 2-pyridinyl or 2-quinolinyl-methoxy-thiophene derivatives | |
| EP0795328A1 (en) | Use of naphthalene derivatives in treating lung carcinoma | |
| CA1075240A (en) | 4,5,6,7-tetrahydroimidazo-(4,5-c)-pyridine derivatives | |
| US4590192A (en) | Benzisothiazoles, their pharmaceutical compositions, and method of use | |
| JPS6412247B2 (enExample) | ||
| EP0105732A2 (en) | Histamine H2 receptor antagonists of the benzisothiazole amino and benzthiadiazine amino series |